VP, U.S. Medical Affairs
Dyne TherapeuticsWaltham, Massachusetts, United States · Posted 2 months agoDescription
Company Overview:
Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. We are developing therapeutics that target muscle and the central nervous system (CNS) to address the root cause of disease. The company is advancing clinical programs for Duchenne muscular dystrophy (DMD) and myotonic dystrophy type 1 (DM1) as well as preclinical programs for facioscapulohumeral muscular dystrophy (FSHD), Pompe disease and multiple DMD mutations. At Dyne, we are on a mission to deliver functional improvement for individuals, families and communities. Learn more at https://www.dyne-tx.com/, and follow us on X, LinkedIn and Facebook.
Role Summary:
The VP, U.S. Medical Affairs is the senior U.S. medical leader with end-to-end accountability for U.S. medical launch readiness, execution, and early commercialization success for Dyne’s first approved product. This role will continue to build, lead, and scale a high-impact U.S. Medical Affairs organization and serve as a critical leader capable of delivering excellence in a first-launch, high‑visibility environment.
This position plays a critical leadership role in shaping Dyne’s transition from a clinical-stage to a commercial-stage company, serving as a core member of cross-functional launch governance and a trusted strategic advisor to executive leadership and member of the US Leadership Team (USLT). The VP is accountable for defining and executing the U.S. medical strategy, ensuring scientific and medical excellence, mitigating medical risk, and driving impactful engagement with U.S. healthcare providers, payers, patient communities, and other external stakeholders.
The VP, U.S. Medical Affairs is a key member of the Global Medical Affairs Leadership Team and works in close collaboration with Global Medical Affairs, Commercial, Market Access, Clinical Development, Regulatory, and other functions to ensure seamless alignment and execution through approval, launch, and early lifecycle management. This is a unique opportunity to define and lead the U.S. medical strategy for Dyne’s first commercial product and establish the foundation for future launches in a rapidly evolving rare disease portfolio.
This role is based in Waltham, MA.
Primary Responsibilities Include:
- Deliver a highly effective U.S. medical launch that enables appropriate, evidence-based adoption
- Establish a credible and trusted Dyne scientific presence with U.S. KOLs, payers, and patient communities
- Build a scalable, high-performing Medical Affairs organization ready for multiple launches
- Effectively translate scientific and clinical data into strategies that drive both access and lifecycle value
- Establish foundational capabilities and ways of working in a first-launch environment
Enterprise & Launch Leadership
- Own U.S. medical strategy, launch readiness, and execution, with direct accountability for delivering multiple successful product launches from a medical affairs perspective
- Build and develop a strong leadership bench, establishing a leadership team capable of scaling with the organization and future launches
- Serve as a core member of cross-functional launch leadership, shaping enterprise decisions and influencing cross-functional tradeoffs, while resolving complex scientific, medical, and operational balance in a time-critical environment
- Ensure U.S. Medical Affairs capabilities, processes, governance, and resourcing are built and operationalized to support launch and early commercialization
- Represent U.S. Medical Affairs scientific priorities and business needs at the US LT and the GMA LT
- Drive culture intentionally during scale
U.S. Medical Affairs Strategy & Execution
- Define, own, and execute the U.S. Medical Affairs strategy aligned with global medical strategy and enterprise objectives
- Ensure aligned cross-functional strategies, goals, and execution in partnership with US LT
- Translate medical and clinical insights into actionable strategies that support appropriate product adoption, evidence generation, payer confidence, and long-term lifecycle value
- Oversee U.S. medical tactics, including KOL strategy, advisory boards, congresses, medical education, payer engagement, and scientific exchange
Organization Building & People Leadership
- Build, lead, and scale a best-in-class U.S. Medical Affairs organization, including Field Medical (Medical Science Liaisons and Medical Value Liaisons) and home-office medical functions, capable of operating with speed, rigor, and scientific credibility while delivering high impact outcomes in a first-launch setting and preparing for subsequent launches
- Establish clear goals, decision rights, accountability, and performance expectations across the organization
- Develop leadership bench strength, foster a culture of ownership and collaboration, and act as a role model for Dyne’s values during a period of rapid organizational growth
- Ensure comprehensive training and learning programs to continuously develop a high performing U.S. Medical Affairs organization
External Engagement & Scientific Leadership
- Serve as Dyne’s senior U.S. medical spokesperson to key external stakeholders, including clinical experts, academic leaders, payers, advocacy groups, and other partners
- Shape and optimize treatment paradigms through credible, compliant, and impactful scientific engagement
- Ensure high-quality, fair-balanced medical and scientific exchange across all U.S. external interactions
- Ensure real-time intelligence on competitive data and evolving treatment paradigm
Evidence Generation & Lifecycle Management
- Provide strategic oversight of U.S.-focused evidence generation, ensuring alignment with launch and lifecycle priorities
- Lead cross-functio
Similar jobs
Est. 140,000 USD
Company Overview: Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. We are developing therapeutics that target muscle and the central nerv…
Est. 250,000 USD
For more than 25 years, Corcept has been singularly focused on the science of cortisol, a powerful hormone that when unregulated, can play a role in a broad range of diseases. Our commercial portfolio includes treatments…
Est. 160,000 USD
Company Overview: Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. We are developing therapeutics that target muscle and the central nerv…
Est. 250,000 USD
Position Summary What if... We could harness the power of Flagship’s scientific platforms and create novel treatment options that benefit more patients, sooner? Pioneering Medicines, an initiative of Flagship Pioneering,…
Company Overview: Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. We are developing therapeutics that target muscle and the central nerv…
Est. 140,000 USD
Company Overview: Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. We are developing therapeutics that target muscle and the central nerv…
Est. 140,000 USD
Company Overview: Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. We are developing therapeutics that target muscle and the central nerv…
Est. 165,000 USD
Company Overview: Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. We are developing therapeutics that target muscle and the central nerv…
Est. 250,000 USD
About Us Kardigan is a heart health company working to make cardiovascular disease preventable, curable and no longer the leading cause of death in the world. It is Kardigan’s mission to develop multiple targeted treatme…
Est. 177,500 USD
Company Overview: Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. We are developing therapeutics that target muscle and the central nerv…
Est. 140,000 USD
Axsome Therapeutics is a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) conditions. We deliver scientific breakthroughs by identifying critical gaps in care and develop diffe…
Est. 140,000 USD
Axsome Therapeutics is a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) conditions. We deliver scientific breakthroughs by identifying critical gaps in care and develop diffe…
Est. 250,000 USD
Company Overview: Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. We are developing therapeutics that target muscle and the central nerv…
Est. 140,000 USD
Axsome Therapeutics is a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) conditions. We deliver scientific breakthroughs by identifying critical gaps in care and develop diffe…
Est. 250,000 USD
About Us Kardigan is a heart health company working to make cardiovascular disease preventable, curable and no longer the leading cause of death in the world. It is Kardigan’s mission to develop multiple targeted treatme…
Est. 140,000 USD
Company Overview: Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. We are developing therapeutics that target muscle and the central nerv…
Est. 140,000 USD
Are you passionate about translating cutting-edge science into meaningful outcomes for patients? Join a collaborative, high-performing medical communications team where your scientific expertise directly informs impactfu…
Est. 140,000 USD
Are you passionate about translating cutting-edge science into meaningful outcomes for patients? Join a collaborative, high-performing medical communications team where your scientific expertise directly informs impactfu…
Est. 185,000 USD
Company Overview: Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. We are developing therapeutics that target muscle and the central nerv…
Est. 165,000 USD
Company Overview Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted cancer therapies. We are advancing an innovative portfolio of therapeutics, suppor…
Est. 85,000 USD
Company Overview: Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. We are developing therapeutics that target muscle and the central nerv…
Est. 120,000 USD
Axsome Therapeutics is a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) conditions. We deliver scientific breakthroughs by identifying critical gaps in care and develop diffe…
Est. 140,000 USD
Axsome Therapeutics is a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) conditions. We deliver scientific breakthroughs by identifying critical gaps in care and develop diffe…
Est. 247,500 USD
Mavericks Wanted When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement...read on In 2015, we pioneered a “moneyball for biotech”…
Est. 165,000 USD
Company Overview Immunome is a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted cancer therapies. We are advancing an innovative portfolio of therapeutics, suppor…
Est. 120,000 USD
Company Description Axsome Therapeutics is a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) conditions. We deliver scientific breakthroughs by identifying critical gaps in ca…
Est. 120,000 USD
Company Description Axsome Therapeutics is a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) conditions. We deliver scientific breakthroughs by identifying critical gaps in ca…
Est. 237,500 USD
Mavericks Wanted When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement...read on In 2015, we pioneered a “moneyball for biotech”…
Est. 205,500 USD
Mavericks Wanted When was the last time you achieved the impossible? If that thought feels overwhelming, you might want to pause here, but if it sparks excitement...read on In 2015, we pioneered a “moneyball for biotech”…
Est. 306,000 USD
Company Overview: Dyne Therapeutics is focused on delivering functional improvement for people living with genetically driven neuromuscular diseases. We are developing therapeutics that target muscle and the central nerv…